Imaging could help tailor treatment of liver tumors

10/24/2013 | MolecularImaging.net

Imaging with SPECT or MR may help evaluate and possibly predict outcomes from radioembolization with Ho-166 microspheres, a team of researchers found. Results of a quantitative analysis of 15 patients who underwent radioembolization published in the Journal of Nuclear Medicine, showed that "using Ho-166 microspheres, in vivo dosimetry based on SPECT and MR imaging correlated well for dose to liver segments and dose to tumors," the authors wrote. In terms of treatment prediction, "Suboptimal treatment can be detected by MR imaging and SPECT, and a pretreatment plan can be elaborated to ensure the full efficacy of the treatment."

View Full Article in:

MolecularImaging.net

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President - Government Products
Health Alliance Plan
Detroit, MI
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Actuary
Meridian Health Plan
Detroit, MI
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
President/Chief Executive Officer
MedCost
Winston-Salem, NC